<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37504277</PMID><DateRevised><Year>2023</Year><Month>07</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1467-3045</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>08</Day></PubDate></JournalIssue><Title>Current issues in molecular biology</Title><ISOAbbreviation>Curr Issues Mol Biol</ISOAbbreviation></Journal><ArticleTitle>Correlation between Hepatocyte Growth Factor (HGF) with D-Dimer and Interleukin-6 as Prognostic Markers of Coagulation and Inflammation in Long COVID-19 Survivors.</ArticleTitle><Pagination><StartPage>5725</StartPage><EndPage>5740</EndPage><MedlinePgn>5725-5740</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3390/cimb45070361</ELocationID><Abstract><AbstractText>In general, an individual who experiences the symptoms of Severe Acute Respiratory Syndrome Coronavirus 2 or SARS-CoV-2 infection is declared as recovered after 2 weeks. However, approximately 10-20% of these survivors have been reported to encounter long-term health problems, defined as 'long COVID-19', e.g., blood coagulation which leads to stroke with an estimated incidence of 3%, and pulmonary embolism with 5% incidence. At the time of infection, the immune response produces pro-inflammatory cytokines that stimulate stromal cells to produce pro-hepatocyte growth factor (pro-HGF) and eventually is activated into hepatocyte growth factor (HGF), which helps the coagulation process in endothelial and epithelial cells. HGF is a marker that appears as an inflammatory response that leads to coagulation. Currently, there is no information on the effect of SARS-CoV-2 infection on serum HGF concentrations as a marker of the prognosis of coagulation in long COVID-19 survivors. This review discusses the pathophysiology between COVID-19 and HGF, IL-6, and D-dimer.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zaira</LastName><ForeName>Bena</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Student at Master Program in Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang 45363, Indonesia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Prodia Education and Research Institute, Jakarta 10430, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yulianti</LastName><ForeName>Trilis</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Prodia Education and Research Institute, Jakarta 10430, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levita</LastName><ForeName>Jutti</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-4578-4174</Identifier><AffiliationInfo><Affiliation>Department of Pharmacology and Clinical Pharmacy, Padjadjaran University, Sumedang 45363, Indonesia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Curr Issues Mol Biol</MedlineTA><NlmUniqueID>100931761</NlmUniqueID><ISSNLinking>1467-3037</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">D-dimer</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">blood coagulation</Keyword><Keyword MajorTopicYN="N">hepatocyte growth factor</Keyword><Keyword MajorTopicYN="N">interleukins</Keyword><Keyword MajorTopicYN="N">pro-inflammatory cytokines</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>28</Day><Hour>13</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>28</Day><Hour>13</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>28</Day><Hour>8</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37504277</ArticleId><ArticleId IdType="pmc">PMC10377933</ArticleId><ArticleId IdType="doi">10.3390/cimb45070361</ArticleId><ArticleId IdType="pii">cimb45070361</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Weekly Epidemiological Update on COVID-19&#x2014;20 April 2023.  [(accessed on 4 May 2023)].  Available online:  https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19-20-april-2023.</Citation></Reference><Reference><Citation>Shi Y., Wang G., Cai X.P., Deng J.-W., Zheng L., Zhu H.-H., Zheng M., Yang B., Chen Z. An overview of COVID-19. J. Zhejiang Univ. Sci. B. 2020;21:343&#x2013;360. doi: 10.1631/jzus.B2000083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1631/jzus.B2000083</ArticleId><ArticleId IdType="pmc">PMC7205601</ArticleId><ArticleId IdType="pubmed">32425000</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu H., Zhong L., Deng J., Peng J., Dan H., Zeng X., Li T., Chen Q. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int. J. Oral Sci. 2020;12 doi: 10.1038/s41368-020-0074-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41368-020-0074-x</ArticleId><ArticleId IdType="pmc">PMC7039956</ArticleId><ArticleId IdType="pubmed">32094336</ArticleId></ArticleIdList></Reference><Reference><Citation>Cascella M., Rajnik M., Aleem A., Dulebohn S.C., Di Napoli R. Features, Evaluation, and Treatment of Coronavirus (COVID-19) StatPearls Publishing; Treasure Island, FL, USA: 2023.</Citation><ArticleIdList><ArticleId IdType="pubmed">32150360</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadam S.B., Sukhramani G.S., Bishnoi P., Pable A.A., Barvkar V.T. SARS-CoV-2, the pandemic coronavirus: Molecular and structural insights. J. Basic Microbiol. 2021;61:180&#x2013;202. doi: 10.1002/jobm.202000537.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jobm.202000537</ArticleId><ArticleId IdType="pmc">PMC8013332</ArticleId><ArticleId IdType="pubmed">33460172</ArticleId></ArticleIdList></Reference><Reference><Citation>Sim B.L.H., Chidambaram S.K., Wong X.C., Pathmanathan M.D., Peariasamy K.M., Hor C.P., Chua H.J., Goh P.P. Clinical characteristics and risk factors for severe COVID-19 infections in Malaysia: A nationwide observational study. Lancet Reg. Health Western Pac. 2020;4:100055. doi: 10.1016/j.lanwpc.2020.100055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanwpc.2020.100055</ArticleId><ArticleId IdType="pmc">PMC7837062</ArticleId><ArticleId IdType="pubmed">33521741</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran A.V., Jayadevan R., Sashidharan S. Long COVID: An overview. Diabetes Metab. Syndr. 2021;15:869&#x2013;875. doi: 10.1016/j.dsx.2021.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Haupert S.R., Zimmermann L., Shi X., Fritsche L.G., Mukherjee B. Global Prevalence of Post-Acute Sequelae of COVID-19 (PASC) or Long COVID: A Meta-Analysis and Systematic Review. J. Infect. Dis. 2022;226:1593&#x2013;1607. doi: 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., Kang L., Guo L., Liu M., Zhou X., et al. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Koc H.C., Xiao J., Liu W., Li Y., Chen G. Long COVID and its Management. Int. J. Biol. Sci. 2022;18:4768&#x2013;4780. doi: 10.7150/ijbs.75056.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.75056</ArticleId><ArticleId IdType="pmc">PMC9305273</ArticleId><ArticleId IdType="pubmed">35874958</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J., Liu S. Proposed subtypes of post-COVID-19 syndrome (or long-COVID) and their respective potential therapies. Rev. Med. Virol. 2022;32:e2315. doi: 10.1002/rmv.2315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2315</ArticleId><ArticleId IdType="pubmed">34888989</ArticleId></ArticleIdList></Reference><Reference><Citation>Long COVID or Post-COVID Conditions. Centers of Disease Control and Prevention. Update 5 Mei 2022.  [(accessed on 15 May 2022)]; Available online:  https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html.</Citation></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;7:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L., Li X., Gu X., Zhang H., Ren L., Guo L., Liu M., Wang Y., Cui D., Wang Y., et al. Articles Health outcomes in people 2 years after surviving hospitalisation with COVID-19: A longitudinal cohort study. Lancet Respir. 2022;2600:863&#x2013;876. doi: 10.1016/S2213-2600(22)00126-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00126-6</ArticleId><ArticleId IdType="pmc">PMC9094732</ArticleId><ArticleId IdType="pubmed">35568052</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical Spectrum of SARS-CoV-2 Infection. American College of Emergency Physician.  [(accessed on 30 March 2022)].  Available online:  https://www.acep.org/corona/covid-19-field-guide/diagnosis/diagnosis-when-there-is-no-testing/</Citation></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. More than 50 Long-term effects of COVID-19: A systematic review and meta-analysis. Sci. Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D., Sun A., Ssentongo A.E., Ba D.M., Parsons N., Poudel G.R., Lekoubou A., Oh J.S., Ericson J.E., Ssentongo P., et al. Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection: A Systematic Review. JAMA Netw. Open. 2021;4:e2128568. doi: 10.1001/jamanetworkopen.2021.28568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>McElvaney O.J., McEvoy N.L., McElvaney O.F., Carroll T.P., Murphy M.P., Dunlea D.M., Ni Choileain O., Clarke J., O&#x2019;connor E., Hogan G., et al. Characterization of the Inflammatory Response to Severe COVID-19 Illness. Am. J. Respir. Crit. Care Med. 2020;202:812&#x2013;821. doi: 10.1164/rccm.202005-1583OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202005-1583OC</ArticleId><ArticleId IdType="pmc">PMC7491404</ArticleId><ArticleId IdType="pubmed">32584597</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang N., Li D., Wang X., Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J. Thromb. Haemost. 2020;18:844&#x2013;847. doi: 10.1111/jth.14768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14768</ArticleId><ArticleId IdType="pmc">PMC7166509</ArticleId><ArticleId IdType="pubmed">32073213</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero D., Chalon P., Kohn L., Dauvrin M., Detollenaere J., Maertens de Noordhout C., Primus-de Jong C., Cleemput I., Van den Heede K. Pathophysiology and mechanism of long COVID: A comprehensive review. Ann. Med. 2022;54:1473&#x2013;1487. doi: 10.1080/07853890.2022.2076901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2076901</ArticleId><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference><Reference><Citation>Valentina O., Puntmann M.D., Carerj M.L., Wieters I., Fahim M., Arendt C., Hoffmann J., Shchendrygina A., Escher F., Vasa-Nicotera M., et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5:1265&#x2013;1273. doi: 10.1001/jamacardio.2020.3557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3557</ArticleId><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrow A.J., Sykes R., McIntosh A., Kamdar A., Bagot C., Bayes H.K., Blyth K.G., Briscoe M., Bulluck H., Carrick D., et al. A multisystem, cardio-renal investigation of post-COVID-19 illness. Nat. Med. 2022;28:1303&#x2013;1313. doi: 10.1038/s41591-022-01837-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01837-9</ArticleId><ArticleId IdType="pmc">PMC9205780</ArticleId><ArticleId IdType="pubmed">35606551</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuzzo D., Cambula G., Bacile I., Rizzo M., Galia M., Mangiapane P., Picone P., Giacomazza D., Scalisi L. Long-Term Brain Disorders in Post Covid-19 Neurological Syndrome (PCNS) Patient. Brain Sci. 2021;11:454. doi: 10.3390/brainsci11040454.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci11040454</ArticleId><ArticleId IdType="pmc">PMC8066611</ArticleId><ArticleId IdType="pubmed">33918426</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin Y., Wu J., Chen T., Li J., Zhang G., Wu D., Zhou Y., Zheng N., Cai A., Ning Q., et al. Long-term microstructure and cerebral blood flow changes in patients recovered from COVID-19 without neurological manifestations. J. Clin. Investig. 2021;131:e147329. doi: 10.1172/JCI147329.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI147329</ArticleId><ArticleId IdType="pmc">PMC8262559</ArticleId><ArticleId IdType="pubmed">33630760</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon J.J., Heyman B., Ko J.P., Condos R., Lynch D.A. CT of Post-Acute Lung Complications of COVID-19. Radiology. 2021;301:E383&#x2013;E395. doi: 10.1148/radiol.2021211396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2021211396</ArticleId><ArticleId IdType="pmc">PMC8369881</ArticleId><ArticleId IdType="pubmed">34374591</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammadi A., Balan I., Yadav S., Matos W.F., Kharawala A., Gaddam M., Sarabia N., Koneru S.C., Suddapalli S.K., Marzban S. Post-COVID-19 Pulmonary Fibrosis. Cureus. 2022;14:e22770. doi: 10.7759/cureus.22770.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.22770</ArticleId><ArticleId IdType="pmc">PMC8974316</ArticleId><ArticleId IdType="pubmed">35371880</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar M.A., Krishnaswamy M., Arul J.N. Post COVID-19 sequelae: Venous thromboembolism complicated by lower GI bleed. BMJ Case Rep. 2021;14:e241059. doi: 10.1136/bcr-2020-241059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2020-241059</ArticleId><ArticleId IdType="pmc">PMC10577728</ArticleId><ArticleId IdType="pubmed">33504542</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira-Junior A.S., Borgonovi T.F., De Salis L.V.V., Leite A.Z., Dantas A.S., De Salis G.V.V., Cruz G.N.F., De Oliveira L.F.V., Gomes E., Penna A.L.B., et al. Detection of Intestinal Dysbiosis in Post-COVID-19 Patients One to Eight Months after Acute Disease Resolution. Int. J. Environ. Res. Public Health. 2022;19:10189. doi: 10.3390/ijerph191610189.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191610189</ArticleId><ArticleId IdType="pmc">PMC9408204</ArticleId><ArticleId IdType="pubmed">36011823</ArticleId></ArticleIdList></Reference><Reference><Citation>Saini L., Krishna D., Tiwari S., Goyal J.P., Kumar P., Khera D., Choudhary B., Didel S., Gadepalli R., Singh K. Post-COVID-19 Immune-Mediated Neurological Complications in Children: An Ambispective Study. Pediatr. Neurol. 2022;136:20&#x2013;27. doi: 10.1016/j.pediatrneurol.2022.06.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pediatrneurol.2022.06.010</ArticleId><ArticleId IdType="pmc">PMC9258417</ArticleId><ArticleId IdType="pubmed">36049379</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Deitchman A.N., Torres L., Iyer N.S., Munter S.E., Nixon C.C., Donatelli J., Thanh C., Takahashi S., Hakim J., et al. Long-Term SARS-CoV-2-Specific Immune and Inflammatory Responses Across a Clinically Diverse Cohort of Individuals Recovering from COVID-19 with and without post-acute symptoms. Cell Rep. 2021;36:109518. doi: 10.1016/j.celrep.2021.109518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109518</ArticleId><ArticleId IdType="pmc">PMC8342976</ArticleId><ArticleId IdType="pubmed">34358460</ArticleId></ArticleIdList></Reference><Reference><Citation>Patell R., Bogue T., Koshy A., Bindal P., Merrill M., Aird W.C., Bauer K.A., Zwicker J.I. Postdischarge thrombosis and hemorrhage in patients with COVID-19. Blood. 2020;136:1342&#x2013;1346. doi: 10.1182/blood.2020007938.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020007938</ArticleId><ArticleId IdType="pmc">PMC7483433</ArticleId><ArticleId IdType="pubmed">32766883</ArticleId></ArticleIdList></Reference><Reference><Citation>Willems L.H., Nagy M., Ten Cate H., Spronk H., Groh L., Leentjens J., Janssen N., Netea M., Thijssen D., Hannink G., et al. Sustained inflammation, coagulation activation and elevated endothelin-1 levels without macrovascular dysfunction at 3 months after COVID-19. Thromb Res. 2022;209:106&#x2013;114. doi: 10.1016/j.thromres.2021.11.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2021.11.027</ArticleId><ArticleId IdType="pmc">PMC8642246</ArticleId><ArticleId IdType="pubmed">34922160</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavoni V., Gianesello L., Pazzi M., Stera C., Meconi T., Frigieri F.C. Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia. J. Thromb. Thrombolysis. 2020;50:281&#x2013;286. doi: 10.1007/s11239-020-02130-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-020-02130-7</ArticleId><ArticleId IdType="pmc">PMC7211560</ArticleId><ArticleId IdType="pubmed">32394236</ArticleId></ArticleIdList></Reference><Reference><Citation>Bikdeli B., Madhavan M.V., Gupta A., Jimenez D., Burton J.R., Der Nigoghossian C., Chuich T., Nouri S.N., Dreyfus I., Driggin E., et al. Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research. Thromb. Haemost. 2020;120:1004&#x2013;1024. doi: 10.1055/s-0040-1713152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1713152</ArticleId><ArticleId IdType="pmc">PMC7516364</ArticleId><ArticleId IdType="pubmed">32473596</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett T.J., Lee A.H., Xia Y., Lin L.H., Black M., Cotzia P., Hochman J., Berger J.S. Platelet and Vascular Biomarkers Associate With Thrombosis and Death in Coronavirus Disease. Circ. Res. 2020;127:945&#x2013;947. doi: 10.1161/CIRCRESAHA.120.317803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.120.317803</ArticleId><ArticleId IdType="pmc">PMC7478197</ArticleId><ArticleId IdType="pubmed">32757722</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M., Verleden S.E., Kuehnel M., Haverich A., Welte T., Laenger F., Vanstapel A., Werlein C., Stark H., Tzankov A., et al. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in COVID-19. N. Engl. J. Med. 2020;383:120&#x2013;128. doi: 10.1056/NEJMoa2015432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2015432</ArticleId><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Connors J.M., Levy J.H. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020;135:2033&#x2013;2040. doi: 10.1182/blood.2020006000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020006000</ArticleId><ArticleId IdType="pmc">PMC7273827</ArticleId><ArticleId IdType="pubmed">32339221</ArticleId></ArticleIdList></Reference><Reference><Citation>Cugno M., Meroni P.L., Gualtierotti R., Griffini S., Grovetti E., Torri A., Panigada M., Aliberti S., Blasi F., Tedesco F., et al. Complement activation in patients with COVID-19: A novel therapeutic target. J. Allergy Clin. Immunol. 2020;146:215&#x2013;217. doi: 10.1016/j.jaci.2020.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.05.006</ArticleId><ArticleId IdType="pmc">PMC7224678</ArticleId><ArticleId IdType="pubmed">32417135</ArticleId></ArticleIdList></Reference><Reference><Citation>Nougier C., Benoit R., Simon M., Desmurs-Clavel H., Marcotte G., Argaud L., David J.S., Bonnet A., Negrier C., Dargaud Y. Hypofibrinolytic state and high thrombin generation may play a major role in SARS-COV2 associated thrombosis. J. Thromb. Haemost. 2020;18:2215&#x2013;2219. doi: 10.1111/jth.15016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15016</ArticleId><ArticleId IdType="pmc">PMC7405476</ArticleId><ArticleId IdType="pubmed">32668058</ArticleId></ArticleIdList></Reference><Reference><Citation>Thachil J. Hypoxia-An overlooked trigger for thrombosis in COVID-19 and other critically ill patients. J. Thromb. Haemost. 2020;18:3109&#x2013;3110. doi: 10.1111/jth.15029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15029</ArticleId><ArticleId IdType="pmc">PMC9770767</ArticleId><ArticleId IdType="pubmed">32726507</ArticleId></ArticleIdList></Reference><Reference><Citation>Middleton E.A., He X.Y., Denorme F., Campbell R.A., Ng D., Salvatore S.P., Mostyka M., Baxter-Stoltzfus A., Borczuk A.C., Loda M., et al. Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood. 2020;136:1169&#x2013;1179. doi: 10.1182/blood.2020007008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020007008</ArticleId><ArticleId IdType="pmc">PMC7472714</ArticleId><ArticleId IdType="pubmed">32597954</ArticleId></ArticleIdList></Reference><Reference><Citation>Jose R.J., Manuel A. COVID-19 cytokine storm: The interplay between inflammation and coagulation. Lancet Respir. Med. 2020;8:e46&#x2013;e47. doi: 10.1016/S2213-2600(20)30216-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30216-2</ArticleId><ArticleId IdType="pmc">PMC7185942</ArticleId><ArticleId IdType="pubmed">32353251</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z., Xiang J., Wang Y., Song B., Gu X., et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020;395:1054&#x2013;1062. doi: 10.1016/S0140-6736(20)30566-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Samkari H., Karp L.R.S., Dzik W.H., Carlson J.C.T., Fogerty A.E., Waheed A., Goodarzi K., Bendapudi P.K., Bornikova L., Gupta S., et al. COVID-19 and coagulation: Bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood. 2020;136:489&#x2013;500. doi: 10.1182/blood.2020006520.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020006520</ArticleId><ArticleId IdType="pmc">PMC7378457</ArticleId><ArticleId IdType="pubmed">32492712</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad F., Kannan M., Ansari A.W. Role of SARS-CoV-2 -induced cytokines and growth factors in coagulopathy and thromboembolism. Cytokine Growth Factor. Rev. 2022;63:58&#x2013;68. doi: 10.1016/j.cytogfr.2021.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2021.10.007</ArticleId><ArticleId IdType="pmc">PMC8541834</ArticleId><ArticleId IdType="pubmed">34750061</ArticleId></ArticleIdList></Reference><Reference><Citation>Boccaccio C. Hepatocyte Growth Factor: A marker and a player in disseminated intravascular coagulation. Thromb. Res. 2011;127:67&#x2013;69. doi: 10.1016/j.thromres.2010.02.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2010.02.014</ArticleId><ArticleId IdType="pubmed">20307902</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung S., Kim J.E., Kim J.Y., Lee D.S., Han K.S., Kim H.K. Circulating hepatocyte growth factor as an independent prognostic factor of disseminated intravascular coagulation. Thromb. Res. 2010;125:e285&#x2013;e293. doi: 10.1016/j.thromres.2010.01.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2010.01.046</ArticleId><ArticleId IdType="pubmed">20185166</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortega-Paz L., Capodanno D., Montalescot G., Angiolillo D.J. Coronavirus Disease 2019-Associated Thrombosis and Coagulopathy: Review of the Pathophysiological Characteristics and Implications for Antithrombotic Management. J. Am. Heart Assoc. 2021;10:e019650. doi: 10.1161/JAHA.120.019650.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.120.019650</ArticleId><ArticleId IdType="pmc">PMC7955431</ArticleId><ArticleId IdType="pubmed">33228447</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Hara H., Wang Y., Esmon C., Cooper D.K.C., Iwase H. Evidence for the important role of inflammation in xenotransplantation. J. Inflamm. 2019;16:10. doi: 10.1186/s12950-019-0213-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12950-019-0213-3</ArticleId><ArticleId IdType="pmc">PMC6537172</ArticleId><ArticleId IdType="pubmed">31148951</ArticleId></ArticleIdList></Reference><Reference><Citation>Goeijenbier M., van Wissen M., van de Weg C., Jong E., Gerdes V., Meijers J., Brandjes D., van Gorp E. Review: Viral infections and mechanisms of thrombosis and bleeding. J. Med. Virol. 2012;84:1680&#x2013;1696. doi: 10.1002/jmv.23354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.23354</ArticleId><ArticleId IdType="pmc">PMC7166625</ArticleId><ArticleId IdType="pubmed">22930518</ArticleId></ArticleIdList></Reference><Reference><Citation>Fazio S., Tufano A., de Simone G. Sustained high D-dimer in outpatients who have recovered from mild to moderate coronavirus disease (COVID-19) Semin. Thromb. Hemost. 2022;48:115&#x2013;117. doi: 10.1055/s-0041-1729857.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0041-1729857</ArticleId><ArticleId IdType="pubmed">33962473</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehmann A., Prosch H., Zehetmayer S., Gysan M.R., Bernitzky D., Vonbank K., Idzko M., Gompelmann D. Impact of persistent D-dimer elevation following recovery from COVID-19. PLoS ONE. 2021;16:e0258351. doi: 10.1371/journal.pone.0258351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0258351</ArticleId><ArticleId IdType="pmc">PMC8553152</ArticleId><ArticleId IdType="pubmed">34710097</ArticleId></ArticleIdList></Reference><Reference><Citation>Fazio S., Vaccariello M., Affuso F. A case of adverse reaction to booster dose of COVID-19: Could D-dimer elevation suggest increased clotting risk? Health. 2022;14:204&#x2013;208. doi: 10.4236/health.2022.142015.</Citation><ArticleIdList><ArticleId IdType="doi">10.4236/health.2022.142015</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosevoll K.A., Lind&#xe5;s R., Tvedt T.H., Bruserud &#xd8;., Reikvam H. Altered plasma levels of cytokines, soluble adhesion molecules and matrix metalloproteases in venous thrombosis. Thromb. Res. 2015;136:30&#x2013;39. doi: 10.1016/j.thromres.2015.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2015.04.002</ArticleId><ArticleId IdType="pubmed">25895848</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z., Shi L., Wang Y., Zhang J., Huang L., Zhang C., Liu S., Zhao P., Liu H., Zhu L., et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8:420&#x2013;422. doi: 10.1016/S2213-2600(20)30076-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30076-X</ArticleId><ArticleId IdType="pmc">PMC7164771</ArticleId><ArticleId IdType="pubmed">32085846</ArticleId></ArticleIdList></Reference><Reference><Citation>Fatima S.H., Viquar U., Ahmed T., Kazmi M.H. The possible immunopathogenesis of SARS-Cov-2 Infection&#x2014;A review of immune changes in patients with COVID-19. Indian J. Pathol. Oncol. 2020;7:519&#x2013;526. doi: 10.18231/j.ijpo.2020.105.</Citation><ArticleIdList><ArticleId IdType="doi">10.18231/j.ijpo.2020.105</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z., Yang B., Li Q., Wen L., Zhang R. Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China. Clin. Infect. Dis. 2020;71:769&#x2013;777. doi: 10.1093/cid/ciaa272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa272</ArticleId><ArticleId IdType="pmc">PMC7184452</ArticleId><ArticleId IdType="pubmed">32176772</ArticleId></ArticleIdList></Reference><Reference><Citation>Coomes E.A., Haghbayan H. Interleukin-6 in Covid-19: A systematic review and meta-analysis. Rev. Med. Virol. 2020;30:1&#x2013;9. doi: 10.1002/rmv.2141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2141</ArticleId><ArticleId IdType="pmc">PMC7460877</ArticleId><ArticleId IdType="pubmed">32845568</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X., Zhao B., Qu Y., Chen Y., Xiong J., Feng Y., Men D., Huang Q., Liu Y., Yang B., et al. Detectable Serum Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load (RNAemia) Is Closely Correlated With Drastically Elevated Interleukin 6 Level in Critically Ill Patients With Coronavirus Disease 2019. Clin. Infect. Dis. 2020;71:1937&#x2013;1942. doi: 10.1093/cid/ciaa449.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa449</ArticleId><ArticleId IdType="pmc">PMC7184354</ArticleId><ArticleId IdType="pubmed">32301997</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Luo S., Shen Y., Li M., Zhang Z., Dong Y. Multiple enzyme release, inflammation storm and hypercoagulability are prominent indicators for disease progression in COVID-19: A multi-centered, correlation study with CT imaging score. SSRN. 2020 doi: 10.2139/ssrn.3544837.</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.3544837</ArticleId></ArticleIdList></Reference><Reference><Citation>Perreau M., Suffiotti M., Marques-Vidal P., Wiedemann A., Levy Y., Laou&#xe9;nan C., Ghosn J., Fenwick C., Comte D., Roger T., et al. The cytokines HGF and CXCL13 predict the severity and the mortality in COVID-19 patients. Nat. Commun. 2021;12:4888. doi: 10.1038/s41467-021-25191-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-25191-5</ArticleId><ArticleId IdType="pmc">PMC8352963</ArticleId><ArticleId IdType="pubmed">34373466</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamayo-Velasco &#xc1;., Pe&#xf1;arrubia-Ponce M.J., &#xc1;lvarez F.J., Gonzalo-Benito H., de la Fuente I., Mart&#xed;n-Fern&#xe1;ndez M., Eiros J.M., Mart&#xed;nez-Paz P., Miramontes-Gonz&#xe1;lez J.P., Fiz-L&#xf3;pez A., et al. Evaluation of Cytokines as Robust Diagnostic Biomarkers for COVID-19 Detection. J. Pers. Med. 2021;11:681. doi: 10.3390/jpm11070681.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm11070681</ArticleId><ArticleId IdType="pmc">PMC8303564</ArticleId><ArticleId IdType="pubmed">34357148</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura T., Mizuno S. The discovery of hepatocyte growth factor (HGF) and its significance for cell biology, life sciences and clinical medicine. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 2010;86:588&#x2013;610. doi: 10.2183/pjab.86.588.</Citation><ArticleIdList><ArticleId IdType="doi">10.2183/pjab.86.588</ArticleId><ArticleId IdType="pmc">PMC3081175</ArticleId><ArticleId IdType="pubmed">20551596</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashem M., Essam T. Hepatocyte growth factor as a tumor marker in the serum of patients with prostate cancer. J. Egypt. Natl. Canc. Inst. 2005;17:114&#x2013;120.</Citation><ArticleIdList><ArticleId IdType="pubmed">16508682</ArticleId></ArticleIdList></Reference><Reference><Citation>Buijsers B., Yanginlar C., de Nooijer A., Grondman I., Maciej-Hulme M.L., Jonkman I., Janssen N.A.F., Rother N., de Graaf M., Pickkers P., et al. Increased Plasma Heparanase Activity in COVID-19 Patients. Front. Immunol. 2020;11:575047. doi: 10.3389/fimmu.2020.575047.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.575047</ArticleId><ArticleId IdType="pmc">PMC7573491</ArticleId><ArticleId IdType="pubmed">33123154</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyce A., Walsh G. Production, characteristics and applications of microbial heparinases. Biochimie. 2022;198:109&#x2013;140. doi: 10.1016/j.biochi.2022.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biochi.2022.03.011</ArticleId><ArticleId IdType="pubmed">35367577</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopec A.K., Luyendyk J.P. Coagulation in liver toxicity and disease: Role of hepatocyte tissue factor. Thromb. Res. 2014;133((Suppl. 1)):S57&#x2013;S59. doi: 10.1016/j.thromres.2014.03.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2014.03.023</ArticleId><ArticleId IdType="pmc">PMC4034136</ArticleId><ArticleId IdType="pubmed">24759146</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Horani R.A. Potential Therapeutic Roles for Direct Factor Xa Inhibitors in Coronavirus Infections. Am. J. Cardiovasc. Drugs. 2020;20:525&#x2013;533. doi: 10.1007/s40256-020-00438-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40256-020-00438-6</ArticleId><ArticleId IdType="pmc">PMC7486161</ArticleId><ArticleId IdType="pubmed">32918208</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia Y., Hu Y., Tang L. Factor XIa Inhibitors as a Novel Anticoagulation Target: Recent Clinical Research Advances. Pharmaceuticals. 2023;16:866. doi: 10.3390/ph16060866.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph16060866</ArticleId><ArticleId IdType="pmc">PMC10300994</ArticleId><ArticleId IdType="pubmed">37375813</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Z., Yang K.Y., Huang Y., Lui K.O. Endothelial contribution to COVID-19: An update on mechanisms and therapeutic implications. J. Mol. Cell Cardiol. 2022;164:69&#x2013;82. doi: 10.1016/j.yjmcc.2021.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2021.11.010</ArticleId><ArticleId IdType="pmc">PMC8610843</ArticleId><ArticleId IdType="pubmed">34838588</ArticleId></ArticleIdList></Reference><Reference><Citation>Costanzo L., Failla G., Grasso S.A., Palumbo S.P., Ardita G., Pino L.D., Mugno F., Finocchiaro P., Aluigi L., Luigi-Antignani P. Coronavirus Disease-19 Pneumonia: The Impact of Coagulopathy. Rev. Mex. Angiol. 2020;48:35&#x2013;37. doi: 10.24875/rma.m20000013.</Citation><ArticleIdList><ArticleId IdType="doi">10.24875/rma.m20000013</ArticleId></ArticleIdList></Reference><Reference><Citation>Szegedi I., Orb&#xe1;n-K&#xe1;lm&#xe1;ndi R., Csiba L., Bagoly Z. Stroke as a Potential Complication of COVID-19-Associated Coagulopathy: A Narrative and Systematic Review of the Literature. J. Clin. Med. 2020;9:3137. doi: 10.3390/jcm9103137.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9103137</ArticleId><ArticleId IdType="pmc">PMC7599722</ArticleId><ArticleId IdType="pubmed">32998398</ArticleId></ArticleIdList></Reference><Reference><Citation>Fletcher-Sandersj&#xf6;&#xf6; A., Bellander B.M. Is COVID-19 associated thrombosis caused by overactivation of the complement cascade? A literature review. Thromb. Res. 2020;194:36&#x2013;41. doi: 10.1016/j.thromres.2020.06.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.06.027</ArticleId><ArticleId IdType="pmc">PMC7301826</ArticleId><ArticleId IdType="pubmed">32569879</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>